Amarin Corp Plc (AMRN)

[Pharmacydude]

Capt
Unless the increased discount happened to all insurance companies prior to the start of Q2 or at most the early weeks of Q2, people should be prepared for another drop in revenues.

Also, product launches are expensive so as things progress in EU (eg Spain) you can expect increasing expenses while also expecting a slow uptake. Doctors are VERY slow and resistant to changing the medications of a Pt for a number of reasons: 1) taught to use the lowest effective dose/drug & avoid adding unless absolutely necessary 2) minimize pill burden 3) if it’s not broken, don’t fix it (and V doesn’t “change” or fix anything 4) no GP wants to be prescribing CVD meds for their pts who have a cardiologist because that’s the cardiologist’s job (except that many cardiologist feel that lipids and BP management is the GP’s job because it’s simple and time consuming).

Prevention just isn’t a priority

This has been my personal experience over the past 3 years.

I don’t see anything positive coming out of the cc but the fact Amarin has blindly followed XBI for the past couple months (thanks to FFS’s chart) reassures me the current SP is a function of the market sector and not a specific problem or impending doom of Amarin operations.

As always Capt, we have to continue to wait.